National Lab Assists Dental Implant Developer with Technical Problems

Information Sessions Coincide with Next Funding Deadline

Monica Abeita

Monica Abeita, Regional Development Corp. for NNM Connect

Three New Mexico men – metallurgist Terry Lowe from Metallicum, a subsidiary of Manhattan Scientifics; designer and manufacturer Dan Blacklock from Danlin Products; and dentist and educator Walt Schuman from BASIC Dental Implants — recently collaborated to develop, manufacture, and market dental implants that use an enhanced variant of titanium made by Manhattan Scientifics. Titanium improves the way dental implants are anchored into the jawbone.

But the team needed special equipment and expertise to evaluate and describe the distinctive characteristics of their breakthrough material, which goes by the trademarked name of Biotanium. The partners applied for help from the New Mexico Small Business Assistance program – a joint project of Los Alamos and Sandia national laboratories and the state of New Mexico. Continue reading

Pricing a Product Takes Research, Objectivity

 

Betsy Gillette

Betsy Gillette, Director of Market Research & Planning, TVC

Pricing a product really isn’t that complicated, even for high-tech products; it’s just a matter of using educated judgment. Before settling on a price, the entrepreneur must assemble facts about the competition and customer base and know what the product cost to produce, among other things.

Continue reading

Fund Accelerates Product Commercialization

Monica Abeita

Monica Abeita, Regional Development Corp. for NNM Connect

A $100,000 award from the Venture Acceleration Fund in 2011 helped Santa Fe startup Vista Therapeutics speed up the commercial introduction of the NanoBioSensor, which employs nanowires to measure in real time the multiple blood proteins and other biomarkers the body produces in response to trauma or disease. Biomarker measurement is especially critical for emergency room doctors, who have little time to gauge the severity of a patient’s condition and choose a proper intervention. Benefits continue during recovery, when ongoing monitoring is essential.

As the first commercially available device capable of such on-the-spot analysis, the NanoBioSensor is expected to improve the lives of people and also reduce the suffering of research animals: Pharmaceutical scientists and other biomedical researchers often must sacrifice many animals to obtain sufficient blood or tissue samples for analysis of biomarker changes over time. The sensitivity and rapidity of Vista’s sensor will allow many biomarkers to be monitored with a simple nick of the research animal’s tail or ear.

Continue reading